These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12230382)

  • 41. Physician awareness of the cardiac effects of methadone: results of a national survey.
    Krantz MJ; Rowan SB; Schmittner J; Bucher Bartelson B
    J Addict Dis; 2007; 26(4):79-85. PubMed ID: 18032235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneous impact of methadone on the QTc interval: what are the practical implications?
    Krantz MJ
    J Addict Dis; 2008; 27(4):5-9. PubMed ID: 19042586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Propoxyphene-induced torsades de pointes.
    Adler A; Viskin S; Bhuiyan ZA; Eisenberg E; Rosso R
    Heart Rhythm; 2011 Dec; 8(12):1952-4. PubMed ID: 21763256
    [No Abstract]   [Full Text] [Related]  

  • 44. [Drug dependence in pregnancy. Better to substitute than complete withdrawal].
    Ottenjann H
    MMW Fortschr Med; 2000 Apr; 142(17):16. PubMed ID: 10879015
    [No Abstract]   [Full Text] [Related]  

  • 45. Methadone-induced mortality in the treatment of chronic pain: role of QT prolongation.
    Andrews CM; Krantz MJ; Wedam EF; Marcuson MJ; Capacchione JF; Haigney MC
    Cardiol J; 2009; 16(3):210-7. PubMed ID: 19437394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Itraconazole-induced torsade de pointes in a patient receiving methadone substitution therapy.
    NoorZurani MH; Vicknasingam B; Narayanan S
    Drug Alcohol Rev; 2009 Nov; 28(6):688-90. PubMed ID: 19930027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Methadone treatment and its dangers].
    Reingardiene D; Jodziūniene L; Lazauskas R
    Medicina (Kaunas); 2009; 45(5):419-25. PubMed ID: 19535889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Long QT and torsade de pointes in a patient with acquired human immunodeficiency virus infection in multitherapy with drugs affecting cytochrome P450].
    Hrovatin E; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Cassin M; Meneguzzo N; Viel E; Lestuzzi C; Di Gennaro G; Nicolosi GL
    Ital Heart J Suppl; 2004 Sep; 5(9):735-40. PubMed ID: 15568612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. When a seizure is not a real seizure!
    Talebi S; Ghobadi F; Chaudhari S; Gracia E; Olatunde O; Pekler G; Visco F; Hassen GW
    Am J Emerg Med; 2016 Apr; 34(4):757.e3-5. PubMed ID: 26409502
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of methadone-induced torsades de pointes with lidocaine.
    Rajpal S; Mundi AS; Reddy PC; Akkus NI
    J La State Med Soc; 2013; 165(6):338-41. PubMed ID: 25073261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Methadone-induced heart arrhythmia].
    Østvold C; Topper M
    Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2021-2. PubMed ID: 16100543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained release oral morphine as an alternative to methadone for the treatment of opioid-use disorder post Torsades de Pointes cardiac arrest.
    Walton G; Nolan S; Sutherland C; Ahamad K
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26392442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. QTc prolongation and torsades de pointes associated with methadone therapy.
    Routhier DD; Katz KD; Brooks DE
    J Emerg Med; 2007 Apr; 32(3):275-8. PubMed ID: 17394991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methadone- and heroin-related deaths in Florida.
    Graham NA; Merlo LJ; Goldberger BA; Gold MS
    Am J Drug Alcohol Abuse; 2008; 34(3):347-53. PubMed ID: 18428077
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.
    Chang KC; Huang CL; Liang HY; Chang SS; Wang YC; Liang WM; Lane HY; Chen CH; Stephen Huang SK
    J Cardiovasc Electrophysiol; 2012 May; 23(5):527-33. PubMed ID: 22136144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.
    Nair MK; Patel K; Starer PJ
    Addiction; 2008 Dec; 103(12):2062-4. PubMed ID: 19469750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Torsade de pointes: a severe and unknown adverse effect in a patient taking methadone].
    Vodoz JF; Jaquier F; Lamy O
    Praxis (Bern 1994); 2003 Oct; 92(41):1748-50. PubMed ID: 14587370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-dose methadone and QTc prolongation: strategies to optimize safety.
    Schmittner J; Krantz MJ
    J Opioid Manag; 2006; 2(1):49-55. PubMed ID: 17319118
    [No Abstract]   [Full Text] [Related]  

  • 60. Effectiveness of methadone maintenance for heroin addiction.
    Murray JB
    Psychol Rep; 1998 Aug; 83(1):295-302. PubMed ID: 9775685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.